Atelocollagen-mediated systemic administration of myostatin-targeting siRNA improves muscular atrophy in caveolin-3-deficient mice.

Source:http://linkedlifedata.com/resource/pubmed/id/21261610

Download in:

View as

General Info

PMID
21261610